Studies on molecular mechanism of thalidomide on GC-rich containing gene involving anchorage independent growth and metastasis
碩士 === 國立陽明大學 === 生物藥學研究所 === 99 === Thalidomide is a potent antiangiogenic drug for cancer therapies. The molecular mechanism of thalidomide was proposed to inhibit the transcription of target genes by binding to the GC promoter sites. It has been demonstrated that the promoters of bFGF and IGF-I g...
Main Authors: | I-Wen Chen, 陳伊玟 |
---|---|
Other Authors: | Rong-Tsun Wu |
Format: | Others |
Language: | zh-TW |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/88881756523854523809 |
Similar Items
-
Comprehensive understanding of anchorage-independent survival and its implication in cancer metastasis
by: Zhong Deng, et al.
Published: (2021-06-01) -
HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth
by: Keita Kanki, et al.
Published: (2020-09-01) -
Effects of Ha-ras oncogene and growth factors on anchorage- independent growth of 212 cells
by: Wen-Chuan Tsai, et al.
Published: (1995) -
The Role of Thrombomodulin in Modulating Anchorage-independent Growth of Tumor Cells
by: Wei-EnChang, et al.
Published: (2010) -
Studies on the Molecular Mechanism of Thalidomide involving Sleep, Autophagy and Memory Consolidation
by: Chun-Chen Lin, et al.
Published: (2013)